Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

Active substance: Teduglutide

The present notice does not concern the award of a public contract within the meaning of the Public Procurement Directive (2014/24/EU) or public procurement law. In the interest of providing as broad information as possible to interested pharmaceutical companies, this notice is published in the Supplement to the Official Journal of the European Union. The procedure designation "Open Procedure" (Section IV.1.1) used in the present notice text is due to the requirements of the notice form. Neither the use of this designation nor the use of the medium "TED" implies any submission to procurement regulations, the applicability of which is not mandatory by law or procurement regulations. This is a framework agreement with an accession option, which relates to various active substances.